Prehn Richmond T, Prehn Liisa M
Department of Pathology, University of Washington, Seattle, WA, USA.
Theor Biol Med Model. 2013 Feb 18;10:12. doi: 10.1186/1742-4682-10-12.
According to Berenblum's two-stage hypothesis, the first stage in carcinogenesis is the production of benign premalignant lesions. Between this initiation stage and the formation of a malignant tumor there is often a long lag phase. We propose that this lag is caused by the delay in the formation of a new and rare tumor-specific antigen, which induces an immune response that stimulates tumor growth. Such tumor-specific antigens could arise as a result of a mutator-like phenotype, which is supposedly present in the benign initial stage of carcinogenesis. According to this hypothesis, the first stage lesion provides a weakly mutagenic environment conducive to the formation of the new antigen(s). If no such new antigens appear so there is no consequent immune response, it is argued that carcinogenesis would seldom if ever ensue.
根据贝伦布卢姆的两阶段假说,致癌作用的第一阶段是产生良性癌前病变。在这个启动阶段和恶性肿瘤形成之间通常有一个很长的延迟期。我们提出,这种延迟是由一种新的、罕见的肿瘤特异性抗原形成延迟所致,这种抗原会诱导一种刺激肿瘤生长的免疫反应。这种肿瘤特异性抗原可能是由于一种类似突变体的表型产生的,这种表型据推测存在于致癌作用的良性初始阶段。根据这一假说,第一阶段病变提供了一个有利于新抗原形成的弱诱变环境。如果没有出现这样的新抗原,因此也就没有随之而来的免疫反应,那么有人认为致癌作用很少会发生。